Cargando…
Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling
Most chronic liver diseases progress to liver fibrosis, which, when left untreated, can lead to cirrhosis and hepatocellular carcinoma. MicroRNA (miRNA)-targeted therapeutics have become attractive approaches to treat diseases. In this study, we investigated the therapeutic effect of miR-155 inhibit...
Autores principales: | Bala, Shashi, Zhuang, Yuan, Nagesh, Prashanth Thevkar, Catalano, Donna, Zivny, Adam, Wang, Yanbo, Xie, Jun, Gao, Guangping, Szabo, Gyongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403732/ https://www.ncbi.nlm.nih.gov/pubmed/37547286 http://dx.doi.org/10.1016/j.omtn.2023.07.012 |
Ejemplares similares
-
MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis
por: Csak, Timea, et al.
Publicado: (2015) -
Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice
por: Momen-Heravi, Fatemeh, et al.
Publicado: (2021) -
Biodistribution and function of extracellular miRNA-155 in mice
por: Bala, Shashi, et al.
Publicado: (2015) -
Alcohol Promotes Exosome Biogenesis and Release via Modulating Rabs and miR-192 Expression in Human Hepatocytes
por: Bala, Shashi, et al.
Publicado: (2022) -
Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection
por: Bala, Shashi, et al.
Publicado: (2012)